Stock Events

Stock Events

Viridian Therapeutics (VRDN) Q1 2025 Earnings

27FebConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-1.15

-1.03

-0.91

-0.79

Details

Expected EPS

-1.03534

Actual EPS

-0.81

Surprise EPS

0.23

Surprise Percent

+21.76%

Description

Viridian Therapeutics (VRDN) has reported earnings of -0.81 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.